Education
About Us
Working with TipRanks
Follow Us
Willow Biosciences (TSE:ATLE)
:ATLE
ATLE Stock Chart & Stats
C$0.16
--
Market closed
C$0.16
--
Day’s Range― - ―
52-Week RangeC$0.02 - C$0.50
Previous CloseN/A
VolumeN/A
Average Volume (3M)26.24K
Market Cap
C$56.36M
Enterprise Value-C$8.51M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.03
Next Earnings
Nov 18, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding352,222,660
10 Day Avg. Volume47,704
30 Day Avg. Volume26,236
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
Willow Biosciences Inc News
ATLE FAQ
What was Willow Biosciences’s price range in the past 12 months?
Willow Biosciences lowest stock price was C$0.02 and its highest was C$0.50 in the past 12 months.
What is Willow Biosciences’s market cap?
Willow Biosciences’s market cap is C$56.36M.
When is Willow Biosciences’s upcoming earnings report date?
Willow Biosciences’s upcoming earnings report date is Nov 18, 2025 which is in 27 days.
How were Willow Biosciences’s earnings last quarter?
Willow Biosciences released its earnings results on Aug 28, 2025. The company reported -C$0.014 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.014.
Is Willow Biosciences overvalued?
According to Wall Street analysts Willow Biosciences’s price is currently Overvalued.
Does Willow Biosciences pay dividends?
Willow Biosciences does not currently pay dividends.
What is Willow Biosciences’s EPS estimate?
Willow Biosciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Willow Biosciences have?
Willow Biosciences has 352,222,660 shares outstanding.
What happened to Willow Biosciences’s price movement after its last earnings report?
Willow Biosciences reported an EPS of -C$0.014 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 14.286%.
Which hedge fund is a major shareholder of Willow Biosciences?
Currently, no hedge funds are holding shares in TSE:ATLE
Willow Biosciences Inc Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-64.44%
12-Months-Change
Fundamentals
Return on Equity
-24.60%
Trailing 12-Months
Asset Growth
729.86%
Trailing 12-Months
Company Description
Willow Biosciences
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin. Willow Biosciences Inc. was incorporated in 1981 and is headquartered in Calgary, Canada.
Technical Analysis
―
City View Green Holdings
―
Ovation Science
―
New Leaf Ventures
―
Silo Wellness Inc
―
Options Prices
Currently, No data available
---